Zandvliet, Anthe S <br/><br/>
Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents.  [electronic resource] 

 -  Investigational new drugs  Feb 2010 
 - 61-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-008-9216-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacokinetics<br/>Clinical Trials, Phase I as Topic<br/>Computer Simulation<br/>Dose-Response Relationship, Drug<br/>Drug Design<br/>Humans<br/>Models, Statistical<br/>Sulfonamides--administration & dosage